Taylor & Francis Group’s Post

Did you know that it takes 17 years for scientific evidence to be adopted into practice? ... Without proper #implementation, research can often be stuck in the "valleys of death," leading to the loss of opportunities and the slow adoption of new and improved treatments that have the potential to improve health outcomes. At NSinga Consultancy, we help companies identify and address country and region-specific barriers in a real-world setting, helping them achieve a #triplewin for patients, #healthcare, and #pharma.

Did you know that GLP-1 drugs have been game changers in healthcare, yet many patients find it difficult to continue the therapy? https://bit.ly/3Wvar0I In our article, we help you understand the issues leading to discontinuation to help improve outcomes and enhance value, which is a significant concern for employers. #healthcare #health #WeightLoss

Did you know that GLP-1 drugs have been game changers in healthcare, yet many patients find it difficult to continue the therapy? https://bit.ly/3Mdk53D In our article, we help you understand the issues leading to discontinuation to help improve outcomes and enhance value, which is a significant concern for employers. #healthcare #health #WeightLoss

Sharing our recently published article that summaries India's progress in institutionalizing evidence-informed priority-setting in healthcare. Explore real-time insights and key considerations for countries navigating their priority-setting journeys. Read the full article and join the thread on the future of HTA in India and other LMICs: https://lnkd.in/g2kN7qnp #hta #cgd #iProSE #HTAIn #healthcareinnovation #evidencebasedmedicine #policyimpact #policyresearch

The MENA has one of the highest out-of-pocket expenditures in the world. High out-of-pocket expenditures for healthcare is often associated with negative health outcomes. Due to poor habits on consumption spending and cases of impoverishment, prescribed treatment plans are often not complied to when we must pay 30% out-of-pocket for those drugs and treatments. Due to the cost that these treatments, screenings, and tests incur, individuals may be less likely to go to see a doctor for minor check-ups or for preventative medicine.

It’s time to reconsider the 3% discount rate.   In a new Value in Health paper, Josh Cohen concludes that declining real interest rates imply that HTA guidance should reduce recommended discount rates to 1.5-2%. This reduction would make projected cost-effectiveness estimates more favorable for therapies with long-term benefits. It would also increase the influence of accounting for long-term drug price dynamics, including reduced prices attending the loss of market exclusivity.   Read more here: https://lnkd.in/e9Qs3xvk

A new approach to heal health system fragmentation - "Health System Kinetics!" It's not just about drug costs. Medicines only account for 11% of total health expenditures. We need to examine the entire ecosystem to tackle the issue of the total US $4 trillion health spend - almost 20% of GDP - twice of what many developed nations allocate. Let's put the patient at the center and determine the value of each piece. By looking at the bigger picture of cost and outcomes, we can arrive at solutions that benefit everyone. #Healthcare #PatientCentered #ValueBasedCare #patientexperience Read More in Medika Life: https://lnkd.in/gAPMxixS

This is a well-reasoned analysis and underlines how sensitive value assessments are even the simplest assumptions. EntityRisk tools can easily show these kinds of sensitivities in a rigorous, transparent and logically consistent framework.

Once you turn 18 you have a higher chance of being prescribed an Opioid compared to someone who is 17 and 11 months. @AnupamBJena , MD, PhD, Economist, Physician, & Author discusses in the full conversation: https://lnkd.in/eZibyUBe. #Health #Healthcare #RandomActsofMedicine

Indian pharma experts urge Budget 2024 to boost health infrastructure, delivery capabilities, and women-centric initiatives. They emphasize the need for promotive and preventive health measures to enhance healthcare and entrepreneurial opportunities for women. #Budget2024 #Pharma #Healthcare #WomenInHealth #PreventiveCare